Rayence Co., Ltd. (KOSDAQ: 228850)

Market Cap	106.22B
Revenue (ttm)	131.29B
Net Income (ttm)	11.21B
Shares Out	15.74M
EPS (ttm)	712.62
PE Ratio	9.47
Forward PE	8.88
Dividend	100.00 (1.48%)
Ex-Dividend Date	Dec 27, 2024

Volume	5,855
Average Volume	9,457
Open	6,680.00
Previous Close	6,600.00
Day's Range	6,520.00 - 6,780.00
52-Week Range	5,620.00 - 9,430.00
Beta	0.93
RSI	66.62
Earnings Date	Feb 14, 2025

About Rayence

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides rad...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 2011
• Employees: 224
• Stock Exchange: KOSDAQ
• Ticker Symbol: 228850

Financial Performance

In 2023, Rayence's revenue was 142.99 billion, a decrease of -2.84% compared to the previous year's 147.16 billion. Earnings were 19.60 billion, a decrease of -11.11%.